rs11652088

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000835.6(GRIN2C):​c.2584-140C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.578 in 1,105,708 control chromosomes in the GnomAD database, including 193,194 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 21295 hom., cov: 32)
Exomes 𝑓: 0.59 ( 171899 hom. )

Consequence

GRIN2C
NM_000835.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.186

Publications

8 publications found
Variant links:
Genes affected
GRIN2C (HGNC:4587): (glutamate ionotropic receptor NMDA type subunit 2C) This gene encodes a subunit of the N-methyl-D-aspartate (NMDA) receptor, which is a subtype of ionotropic glutamate receptor. NMDA receptors are found in the central nervous system, are permeable to cations and have an important role in physiological processes such as learning, memory, and synaptic development. The receptor is a tetramer of different subunits (typically heterodimer of subunit 1 with one or more of subunits 2A-D), forming a channel that is permeable to calcium, potassium, and sodium, and whose properties are determined by subunit composition. Alterations in the subunit composition of the receptor are associated with pathophysiological conditions such as Parkinson's disease, Alzheimer's disease, depression, and schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
GRIN2C Gene-Disease associations (from GenCC):
  • Alzheimer disease
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.626 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2CNM_000835.6 linkc.2584-140C>T intron_variant Intron 12 of 12 ENST00000293190.10 NP_000826.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2CENST00000293190.10 linkc.2584-140C>T intron_variant Intron 12 of 12 1 NM_000835.6 ENSP00000293190.5
GRIN2CENST00000584176.1 linkn.6327-140C>T intron_variant Intron 8 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.502
AC:
76275
AN:
151860
Hom.:
21298
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.278
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.546
Gnomad ASJ
AF:
0.458
Gnomad EAS
AF:
0.264
Gnomad SAS
AF:
0.420
Gnomad FIN
AF:
0.640
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.631
Gnomad OTH
AF:
0.487
GnomAD4 exome
AF:
0.590
AC:
562371
AN:
953732
Hom.:
171899
AF XY:
0.585
AC XY:
279315
AN XY:
477482
show subpopulations
African (AFR)
AF:
0.261
AC:
5759
AN:
22052
American (AMR)
AF:
0.590
AC:
13186
AN:
22350
Ashkenazi Jewish (ASJ)
AF:
0.471
AC:
8921
AN:
18954
East Asian (EAS)
AF:
0.267
AC:
8884
AN:
33252
South Asian (SAS)
AF:
0.443
AC:
27169
AN:
61292
European-Finnish (FIN)
AF:
0.645
AC:
20537
AN:
31846
Middle Eastern (MID)
AF:
0.392
AC:
1230
AN:
3136
European-Non Finnish (NFE)
AF:
0.632
AC:
453550
AN:
717888
Other (OTH)
AF:
0.538
AC:
23135
AN:
42962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
11671
23342
35014
46685
58356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10540
21080
31620
42160
52700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.502
AC:
76272
AN:
151976
Hom.:
21295
Cov.:
32
AF XY:
0.502
AC XY:
37292
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.278
AC:
11504
AN:
41436
American (AMR)
AF:
0.546
AC:
8349
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.458
AC:
1586
AN:
3466
East Asian (EAS)
AF:
0.264
AC:
1359
AN:
5150
South Asian (SAS)
AF:
0.419
AC:
2016
AN:
4814
European-Finnish (FIN)
AF:
0.640
AC:
6762
AN:
10564
Middle Eastern (MID)
AF:
0.374
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
0.631
AC:
42904
AN:
67948
Other (OTH)
AF:
0.484
AC:
1020
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1759
3519
5278
7038
8797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.573
Hom.:
6039
Bravo
AF:
0.485
Asia WGS
AF:
0.354
AC:
1236
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
7.0
DANN
Benign
0.64
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11652088; hg19: chr17-72839832; API